(Phys.org)—The market value for deuterated drugs has recently been estimated at over a billion dollars. Such drugs are simply molecules in which one or more hydrogen atoms are replaced with deuterium. While these kinds of manipulations are known to work wonders as far as breathing unique life into aging patents,the overall therapeutic value of this medical manna can be contentious. A recent paper published in PLoS ONE seeks to explain the 'quantum nature of drug-receptor interactions' under deuteration using a combined experimental and computational approach. Although a tall order, a more comprehensive and predictive theory of receptor interactions is sorely needed. Perhaps a theory in which the molecular character of drug effects are written less into the receptor and more into the drug itself.
Source: phys.org